Tianjin Tianyao Pharmaceuticals (600488.SH) has obtained a food production license.
Tianjin Pharmaceutical Group Co., Ltd. (600488.SH) announced that the company has recently received a notice from the Tianjin Binhai New Area Market Supervision Administration...
Tianjin Tianyao Pharmaceuticals (600488.SH) announced that the company recently received a "Food Production License" issued by the Market Supervision Administration of Binhai New Area, Tianjin. The category is food additives. The certificate specifies the detailed varieties of additives as follows: L-lysine hydrochloride (purified), L-proline (purified), L-arginine (purified), L-threonine (purified), L-glutamine (purified), L-leucine (purified), L-isoleucine (purified), L-phenylalanine (purified), L-tryptophan (purified), glycine (purified), L-aspartic acid (purified), L-serine (purified), L-cysteine (purified), L-cystine (purified), L-cystine hydrochloride monohydrate (purified), L-arginine hydrochloride (purified), L-histidine monohydrate hydrochloride (purified), L-tyrosine (purified), L-methionine (purified), L-proline (purified), L-histidine (purified), N-acetyl-L-cysteine (purified), L-norvaline hydrochloride (purified), L-lysine (purified), L-lysine acetate (purified).
Related Articles

Beisen Holding (09669) spent 3.239 million Hong Kong dollars on October 20 to repurchase 40,060 shares.

Oracle Corporation (ORCL.US) ambitious goals have received positive evaluations from analysts, but customer concentration risks are still a concern.

DeepSeek team releases new visual compression model DeepSeek-OCR
Beisen Holding (09669) spent 3.239 million Hong Kong dollars on October 20 to repurchase 40,060 shares.

Oracle Corporation (ORCL.US) ambitious goals have received positive evaluations from analysts, but customer concentration risks are still a concern.

DeepSeek team releases new visual compression model DeepSeek-OCR

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025